Retail sale of pharmaceutical products
AB-FARMA AS
Revenue 2024
NOK 0
Operating profit
NOK −35,000
Equity
NOK −21,000
Incorporated
2023
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 0 | |
| Total operating costs | 35k | |
| Operating profit (EBIT) | −35k | |
| Net financial items | −5k | |
| Profit for the year | −40k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 8.1m | |
| of which current assets | 9k | |
| Equity | −21k | |
| Total liabilities | 8.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.